Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 30, 2001 - Issue 2
43
Views
4
CrossRef citations to date
0
Altmetric
Original

EFFECTIVENESS OF AN INFLUENZA VACCINE USED IN POLAND IN THE 1998–1999 INFLUENZA SEASON

, , &
Pages 103-113 | Published online: 31 May 2001

REFERENCES

  • Scholtissek C. Source for Influenza Pandemics. Eur. J. Epidemiol 1994; 4: 455–458
  • Anonymus. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. MMWR Morb. Mortal. Weekly Rep. 1996; 45(RR-5)1–24
  • Wilde J. A., McMillan J. A., Serwint J., Butta J., O'Riordan M. A., Steinhoff M. C. Effectiveness of Influenza Vaccine in Health Care Professionals. J. Am. Med. Acad. 1999; 281: 908–913
  • Kavet J. A Perspective on the Significance of Pandemic Influenza. Am. J. Public Health 1977; 67: 1063–1070
  • Barker W. H. Excess Pneumonia and Influenza Associated Hospitalization during Influenza Epidemics in the United States, 1970–78. Am. J. Public Health 1986; 76: 761–765
  • Long J. K., Mossad S. B., Goldman M. P. Antiviral Agents for Treating Influenza. Cleve. Clin. J. Med. 2000; 67: 92–95
  • Osterhaus A. D, de Jong J. C. The Control of Influenza: Antivirals as an Adjunct to Vaccines. Vaccine 1999; 18: 779–780
  • La Montagne J. R., Noble G. R., Quinnan G. V., Curlin G. T., Blackwelder W. C., Smith J. I., Ennis F. A., Bozeman F. M. Summary of Clinical Trials of Inactivated Influenza Vaccine – 1978. Rev. Infect. Dis. 1983; 5: 723–736
  • Oxford J. S., Schild G. C., Potter C. W., Jennings R. The Specificity of the Anti-haemagglutinin Antibody Response Induced in Man by Inactivated Influenza Vaccines and by Natural Infection. J. Hygiene 1979; 82: 51–61
  • Dorrell L., Hassan I., Marshall S., Chakraverty P., Ong E. Clinical and Serological Responses to an Inactivated Influenza Vaccine in Adults with HIV Infection, Diabetes, Obstructive Airways Disease, Elderly Adults and Healthy Volunteers. Int. J. Std. AIDS 1997; 8: 776–779
  • McElhaney J. E., Beattie B. L., Devine R., Grynoch R., Toth E. L., Bleackly R. C. Age–related Decline in Interleukin 2 Production in Response to Influenza Vaccine. J. Am. Geriatr. Soc. 1990; 38: 652–658
  • Gross P. A., Hermogenes A. W., Sachs H. S., Lau J., Levandowski R. A. The Efficacy of Influenza Vaccine in Elderly Persons. A Meta-analysis and Review of the Literature. Ann. Intern. Med. 1995; 123: 518–527
  • Schoenbaum S. C. Economic Impact of Influenza. The Individual's Perspective. Am. J. Med. 1987; 82: 26–30
  • Anonymus. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention. MMWR Morb. Mortal. Weekly Rep. 1998; 47(RR-6)1–26
  • Edmondson W. P., Jr., Rothenberg R., White P. W., Gwaltney G. M., Jr. A Comparison of Subcutaneous, Nasal, and Combined Influenza Vaccination. II. Protection against Natural Challenge. Am. J. Epidemiol. 1971; 93: 480–486
  • Alexseiev A., Van Hung N., Wood S. C. Effectiveness and Economical Impact of Vaccination against Influenza among a Working Population in Moscow. Summary of Speeches. 4th European Conference on Vaccinology, European Commission: Brussels 1999, BrightonUK 1999
  • Bernstein D. I., Cherry J. D. Am. J. Dis. Child 1983; 137: 622–626
  • Nichol K. L., Lind A., Margolis K. L., Murdoch M., McFadden R., Hauge M., Magnan S., Drake M. The effectiveness of Vaccination against Influenza in Healthy, Working Adults. New Engl. J. Med. 1995; 333: 889–893
  • Dille J. H. A Worksite Influenza Immunization Program. Impact on Lost Work Days, Health Care Utilization, and Health Care Spending. AAOHN J. 1999; 47: 301–309
  • Kressin B. W., Hallauer J. F. Influenza: Oekonomische Bedeutung der Schutzimpfung. Deutsches Aerzteblatt 1999; 96: A–342–343
  • Nicholson K. G., Nguyen-Van-Tam J. S., Ahmed A. H., Wiselka M. J., Leese J., Ayres J., Campbell J. H., Ebden P., Eiser N. M., Hutchcroft B. J., Pearson J. C., Willey R. F., Wolstenholme R. J., Woodhead M. A. Randomised Placebocontrolled Crossover Trial on Effect of Inactivated Influenza Vaccine on Pulmonary Function in Asthma. Lancet 1998; 352: 326–331
  • Nichol K. L., Margolis K. L., Lind A., Murdoch M., McFadden R., Hauge M., Magnan S., Drake M. Side Effects Associated with Influenza Vaccination in Healthy Working Adults. A Randomized, Placebo-controlled Trial. Arch. Intern. Med. 1996; 156: 1546–1550
  • Barry D. W., Mayner R. E., Staton E., Dunlap R. C., Rastogi S. C., Hannah J. E., Blackburn R. J., Nortman D. F., Graze P. R. Comparative Trial of Influenza Vaccines. I. Immunogenicity of Whole Virus and Split Product Vaccines in Man. Am. J. Epidemiol. 1976; 104: 34–46
  • Barry D. W., Mayner R. E., Hochstein H. D., Dunlap R. C., Rastogi S. C., Hannah J. E., Blackburn R. J., Sullivan J. L., Gerety R. J. Comparative Trial of Influenza Vaccines. II. Adverse Reactions in Children and Adults. Am. J. Epidemiol. 1976; 104: 47–59

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.